Abbott starts groundbreaking carotid artery stenting trial
This article was originally published in Clinica
Looking to expand the use of carotid artery stents, Abbott Laboratories is to test the devices in patients who would normally undergo surgery to treat blockages in their carotid arteries.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.